转移性非小细胞肺癌的精准治疗：概念概述。
Precision treatment for metastatic non-small cell lung cancer: A conceptual overview.
机构信息
Columbia University Irving Medical Center, Department of Internal Medicine, New York, NY.
Duke Cancer Institute, Durham, NC.
出版信息
Cleve Clin J Med. 2021 Feb 1;88(2):117-127. doi: 10.3949/ccjm.88a.19148.
PMID:33526466
Abstract
Recent developments in precision oncology have increased the complexity of diagnostic and therapeutic decisions. Here, we broadly review the field of precision oncology and discuss common mutational drivers in non-small cell lung cancer (NSCLC) that directly relate to the diagnosis, evaluation, and treatment of patients with metastatic disease.
摘要
精准肿瘤学的最新进展增加了诊断和治疗决策的复杂性。在这里，我们广泛回顾了精准肿瘤学领域，并讨论了非小细胞肺癌（NSCLC）中常见的突变驱动因素，这些因素直接与转移性疾病患者的诊断、评估和治疗相关。
Zotero 插件